Public trial registry of the CCC-Munich

Trial CRAD001C2454

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CRAD001C2454
World
Full title
:

Multizentrische, einarmige, zweistufige Phase-II-Studie mit RAD001 (Everolismus) mit Glivec bei Glivec-resistenten Patienten mit progressivem GIST

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
- Gastrointestinal tumors
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
IV
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2012-11-30 / 2013-07-02
Participants
Function Prename Surname Organization
World Principal Investigator Lars Lindner Keine Organisationseinheit angegeben Magnifier